Inventor · disambiguated record
Bernhard Mueller
Also filed as: MUELLER BERNHARD · MUELLER BERNHARD K · MUELLER BERNHARD KLAUS
21 granted patents·32 pending applications·116 citations·filing 2001–2025
95Inventor score
Top patents by PatentIndex Score
53 records- 0195US9109026B2Dual variable domain immunoglobulins and uses thereofGHAYUR TARIQ·Filed 2009·Granted Aug 18, 2015·30 cites·20 claims
- 0294US12098192B2Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2024·Granted Sep 24, 2024·2 cites·20 claims
- 0392US10822403B2Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2018·Granted Nov 3, 2020·5 cites·14 claims
- 0491US12098189B2Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2020·Granted Sep 24, 2024·2 cites·24 claims
- 0590US12365729B2Anti-hemojuvelin (HJV) antibodies for treating myelofibrosisDISC MEDICINE INC·Filed 2024·Granted Jul 22, 2025·1 cites·30 claims
- 0687US10118958B2Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2012·Granted Nov 6, 2018·9 cites·38 claims
- 0786US9102722B2Composition and method for the diagnosis and treatment of diseases associated with neurite degenerationABBVIE DEUTSCHLAND·Filed 2013·Granted Aug 11, 2015·6 cites·5 claims
- 0886US2025179159A1Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2024·Application pending·0 cites
- 0985US7981420B2Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)MAX PLANCK GESELLSCHAFT·Filed 2001·Granted Jul 19, 2011·26 cites·12 claims
- 1085US2025304672A1Methods for treating spinal cord injury and painABBVIE INC·Filed 2024·Application pending·0 cites
- 1184US10106602B2Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereofABBVIE DEUTSCHLAND·Filed 2016·Granted Oct 23, 2018·3 cites·11 claims
- 1283US9605069B2Antibodies against the RGM a protein and uses thereofABBVIE DEUTSCHLAND·Filed 2015·Granted Mar 28, 2017·3 cites·11 claims
- 1381US12497452B2Anti-hemojuvelin (HJV) antibodies for treating myelofibrosisDISC MEDICINE INC·Filed 2025·Granted Dec 16, 2025·0 cites·28 claims
- 1481US9636398B2Composition and method for the diagnosis and treatment of iron-related disordersABBVIE DEUTSCHLAND·Filed 2012·Granted May 2, 2017·5 cites·16 claims
- 1581US8680239B2Use of RGM and its modulatorsMUELLER BERNHARD K·Filed 2012·Granted Mar 25, 2014·7 cites·5 claims
- 1680US8962803B2Antibodies against the RGM A protein and uses thereofMUELLER BERNHARD K·Filed 2009·Granted Feb 24, 2015·3 cites·69 claims
- 1780US7771952B2Modulators and modulation of the interaction between RGM and NeogeninABBOTT LAB·Filed 2003·Granted Aug 10, 2010·8 cites·2 claims
- 1877US8445686B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsMACK HELMUT·Filed 2008·Granted May 21, 2013·3 cites·21 claims
- 1975US9175075B2Methods of treating retinal nerve fiber layer degeneration with monoclonal antibodies against a retinal guidance molecule (RGM) proteinMUELLER BERNHARD K·Filed 2010·Granted Nov 3, 2015·2 cites·8 claims
- 2074US9365643B2Antibodies that bind to repulsive guidance molecule A (RGMA)ABBVIE DEUTSCHLAND·Filed 2014·Granted Jun 14, 2016·1 cites·13 claims
- 2171US2021238270A1Composition and method for the diagnosis and treatment of diseases associated with neurite degenerationABBVIE DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 2271US2023174645A1Anti-hemojuvelin (hjv) antibodies for treating myelofibrosisDISC MEDICINE INC·Filed 2021·Application pending·0 cites
- 2371US2021230260A1Antibodies against the rgm a protein and uses thereofABBVIE DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 2471US2022018855A1RGMa Fragment Based Diagnostic AssayABBVIE DEUTSCHLAND·Filed 2021·Application pending·0 cites
- 2571US2022025031A1Methods for treating spinal cord injury and painABBVIE INC·Filed 2021·Application pending·0 cites
- 2670US2021277097A1Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degenerationABBVIE DEUTSCHLAND·Filed 2020·Application pending·0 cites
- 2769US2020347123A1Methods for treating spinal cord injury and painABBVIE INC·Filed 2019·Application pending·0 cites
- 2865US7906120B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR)ABBOTT LAB·Filed 2007·Granted Mar 15, 2011·0 cites·21 claims
- 2964US2019276526A1Composition and method for the diagnosis and treatment of diseases associated with neurite degenerationABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 3063US9255146B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereofABBVIE DEUTSCHLAND·Filed 2013·Granted Feb 9, 2016·0 cites·6 claims
- 3163US2019233510A1NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOFABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 3261US10040852B2Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereofABBVIE DEUTSCHLAND·Filed 2016·Granted Aug 7, 2018·0 cites·14 claims
- 3360US2013330347A1Composition and method for the diagnosis and treatment of diseases associated with neurite degenerationABBVIE DEUTSCHLAND·Filed 2013·Application pending·0 cites
- 3460US2018162933A1Antibodies against the rgm a protein and uses thereofABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 3559US2024417458A1Methods for treating anemia of kidney diseaseDISC MEDICINE INC·Filed 2022·Application pending·0 cites
- 3659US2020241012A1RGMa Fragment Based Diagnostic AssayABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 3758US2017166633A1Antibodies against the rgm a protein and uses thereofABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 3856US2017114129A1Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degenerationABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 3956US2017349653A1Methods for treating spinal cord injury and painABBVIE INC·Filed 2017·Application pending·0 cites
- 4056US2013101605A1Modulators and modulation of the interaction between rgm and neogeninSTRITTMATTER STEPHEN·Filed 2012·Application pending·0 cites
- 4154US2011142845A1NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOFABBOTT LAB·Filed 2010·Application pending·0 cites
- 4253US2016075773A1Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degenerationABBVIE DEUTSCHLAND·Filed 2015·Application pending·0 cites
- 4351US2023183339A1Anti-hemojuvelin (hjv) antibodies for treating anemia of chronic diseaseDISC MEDICINE INC·Filed 2021·Application pending·0 cites
- 4451US2011003971A1Modulators and modulation of the interaction between rgm and neogeninABBOTT LAB·Filed 2010·Application pending·0 cites
- 4548US2016032000A1Blood-brain-barrier dual variable domain immunoglobulins and uses thereofABBVIE INC·Filed 2015·Application pending·0 cites
- 4648US2016069907A1RGMa Fragment Based Diagnostic AssayABBVIE DEUTSCHLAND·Filed 2015·Application pending·0 cites
- 4747US2019247503A1Methods for treating relapsing forms of multiple sclerosisABBVIE INC·Filed 2018·Application pending·0 cites
- 4847US2015183867A1Dual variable domain immunoglobulins and uses thereofABBVIE INC·Filed 2015·Application pending·0 cites
- 4946US2010322948A1Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of sameABBOTT GMBH & CO KG·Filed 2008·Application pending·0 cites
- 5044US2011112280A1Use of rgm and its modulatorsMUELLER BERNHARD K·Filed 2010·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →